Sources: AP
Sri Lanka begins its COVID-19 vaccination rollout for children between the ages of 12 and 15 years using the Pfizer-BioNTech COVID-19 vaccine. 2022-01-7
Mexican health regulator COFEPRIS grants emergency use authorization for Merck & Co.'s anti-COVID-19 drug Molnupiravir for the treatment of severe disease. 2022-01-7
The Centers for Disease Control and Prevention recommends that people as young as 16 years receive a booster dose of the COVID-19 vaccine. This comes after the FDA authorized the usage of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for people in that age group. 2021-12-9
Iraq receives 1.2 million doses of the Pfizer–BioNTech COVID-19 vaccine through the COVAX initiative. 2021-11-20
British Columbia announces that beginning from January 2022, the province will offering a booster dose of either the Pfizer or Moderna vaccine to people aged above 12 years old who have already received their second dose, becoming the first jurisdiction in North America to do so. 2021-10-26
Australia expands eligibility for the Pfizer–BioNTech and Moderna COVID-19 vaccines to include seniors over the age of 60 who had previously only been eligible for the Oxford–AstraZeneca vaccine. 2021-10-1
The Food and Drug Administration gives full approval to the Pfizer–BioNTech COVID-19 vaccine, becoming the first vaccine in the U.S. to be granted full licensure and thereby giving businesses, schools and universities more confidence to adopt vaccine mandates. 2021-08-23
Italy suspends the use of the Oxford-AstraZeneca vaccine in people under the age of 60 nationwide following the death of an 18-year-old girl yesterday and reports of other young people who have been hospitalized in critical condition after receiving their first dose of the vaccine. The Moderna and Pfizer vaccines will be used for the vaccination of people under the age of 60, including for people who already received a first dose of the AstraZeneca vaccine. 2021-06-11
White House COVID-19 Response Coordinator Jeff Zients says that the Biden administration will accelerate doses of the Pfizer-BioNTech and Moderna vaccines. The move comes after the United States suspended usage of the Johnson & Johnson vaccine. 2021-04-14
The Therapeutic Goods Administration approves the Pfizer–BioNTech vaccine for use in Australia. 2021-01-25